NIH to launch human safety study of ebola vaccine candidate
Initial human testing of an investigational vaccine to prevent Ebola virus disease will begin next week by the National Institute of Allergy and Infectious Diseases. The early-stage trial will begin initial human testing of a vaccine co-developed by NIAID and GlaxoSmithKline. August 28, 2014